Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

beclobrinic acid

Known as: 2-(4 ((4-chlorophenyl)methyl)phenoxy)-2-methyl butanoic acid, beclobric acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
The effect of hypolipidaemic compounds on peroxisomal fatty acid β-oxidation and on peroxisome morphology in the liver differs… 
  • figure I
  • table 1
  • figure 2
  • table 2
  • figure 3
1993
1993
Acyl glucuronides are known to be labile conjugates, which undergo hydrolysis and bind irreversibly to proteins. The lipid… 
1993
1993
The chiral lipid regulating agent beclobrate (CAS 55937-99-0), which was marketed as racemate, is - like clofibrate - rapidly… 
1991
1991
The major biotransformation pathway for the chiral lipid-regulating agent beclobrate is conversion to the corresponding… 
Highly Cited
1990
Highly Cited
1990
The peroxisome-proliferating effects of clofibric acid and beclobric acid were studied in primary cultures of hepatocytes derived… 
1990
1990
The lipid-reducing effects of a new fibric acid derivative (beclobrate, 100 mg/day), L-carnitine (15 mg/ kg b.w. thrice weekly i… 
1987
1987
Beclobrate [2-(4-[(4-chlorophenyl)methyl]phenoxy)-2-methylbutyric acid ethyl ester], a structural analog of clofibrate, is used… 
1987
1987
The pharmacokinetics of beclobrate (ethyl(+/-)-2-[[alpha-(p-chlorophenyl)-p-tolyl]-oxy]-2-methylbutyrate, SGD 24774), a new lipid… 
1985
1985
Effects and the mechanism of the antiplatelet actions of beclobrinic acid, free acid form of a new hypolipidemic agent beclobrate… 
1985
1985
The major pathway of biotransformation of beclobrate [(2-[4-[(4-chlorophenyl)methyl]phenoxy]-2-methylbutyric acid ethyl ester] is…